Subscribe: Market Wire - Medical and Healthcare: Surgery and Treatments
http://img.marketwire.com/rss/mwMHSU.rss
Added By: Feedage Forager Feedage Grade A rated
Language: English
Tags:
announced  announces  cannabis  company  jul  marketwired jul  marketwired  media  medical  new  otc pink  technology  today 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: Market Wire - Medical and Healthcare: Surgery and Treatments

Marketwired - Surgery and Treatments



Marketwired - Surgery and Treatments



Last Build Date: Thu, 20 Jul 2017 13:50:29 EDT

Copyright: Copyright: (C) Marketwired
 



ECPO Files Issuers Company Related Action Notification with the Financial Industry Regulatory Authority requesting Name and Symbol Change

Thu, 20 Jul 2017 13:19:52 EDT

The Company Also Updated Progress on the Validation Process for its ITV-1 Patented HIV/AIDS Treatment




DirectTrust Reports Steady Growth in Number of Direct Exchange Users, Addresses and Transactions during Second Quarter

Thu, 20 Jul 2017 09:30:00 EDT

Five new members join DirectTrust since April 1




MTBC Named in 2017 Ranking of the Top 15 Medical Billing Companies in the United States

Thu, 20 Jul 2017 09:15:08 EDT

SOMERSET, NJ--(Marketwired - Jul 20, 2017) - MTBC (NASDAQ: MTBC) (NASDAQ: MTBCP), a leading provider of proprietary, cloud-based healthcare IT solutions and services, today announced that it has been ranked as one of the top 15 medical billing companies in the United States, according to Becker's Hospital Review.




SANUWAVE Appoints Alat Medika Indonesia as Distributor for dermaPACE and Liaison to Clinical Trials Participation for Company's Wound Care Product(s) in Indonesia

Thu, 20 Jul 2017 09:00:00 EDT

SUWANEE, GA--(Marketwired - Jul 20, 2017) - SANUWAVE Health, Inc. (OTCQB: SNWV) is pleased to announce that the Company has appointed Alat Medika Indonesia as distributor for dermaPACE® and liaison for clinical trials participation for Company's wound care product in Indonesia. The expected revenue from this agreement will be north of $1 million over the next three years.




Medical Marijuana Reports Record Month of Sales -- CFN Media

Thu, 20 Jul 2017 09:00:00 EDT

SEATTLE, WA--(Marketwired - Jul 20, 2017) -  CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article on Medical Marijuana Inc.'s (OTC PINK: MJNA) Kannaway® subsidiary and its record monthly sales in June.




Propanc Biopharma Receives Acceptance of Key Patent Application for Cancer Treatment in China

Thu, 20 Jul 2017 08:30:00 EDT

Patent covers use of a pharmaceutical composition comprising trypsinogen and chymotrypsinogen




Increased Revenues, Refill Gains Identified by American Pharmacies as Top Benefits of RxCOMPASS, Powered by FDS Inc.'s myDataMart

Thu, 20 Jul 2017 08:30:00 EDT

Buying cooperative shares study results demonstrating financial gains generated by robust pharmacy business intelligence tool




Philadelphia Plastic Surgeon Named One of "America's Top Doctors" for 17th Consecutive Year

Thu, 20 Jul 2017 08:01:00 EDT

Castle Connolly has identified Louis P. Bucky, MD as a 2017 "Top Doctor" in plastic surgery




Company Announces Continued Development of its Online Presence and Ongoing Negotiations for an Extraction Joint-Venture to Satisfy CBD Oil Demand in the Northeast

Thu, 20 Jul 2017 08:00:00 EDT

NEW YORK, NY--(Marketwired - Jul 20, 2017) - HempAmericana, Inc. (OTC PINK: HMPQ) is proud to announce it is now selling CBD oil off its newly designed website www.hempamericana.net. It is important for the company to continue its retail sales while it develops a hemp extraction process directly under its control. The company's CEO Salvador Rosillo stated, "We are extremely excited to have retail sales as a base, while we develop our own internal extraction process. While these early sales are financially nominal and the orders are small, we will implement a SEO program that will target markets to sell our oils into in the near future."




Clinical Teams From Top Pharma Companies Are Overcoming Challenges in Planning and Implementing Adaptive Trial Design Studies

Wed, 19 Jul 2017 19:23:00 EDT

RESEARCH TRIANGLE PARK, NC--(Marketwired - July 19, 2017) - A recent study of Top 10, Top 50, and small medical device companies found that addressing regulators' concerns for late-stage studies is the most common challenge clinical development teams encounter during their adaptive trial design preparations, according to research published by business intelligence firm Cutting Edge Information.




ORHub, Inc. Executing Aggressive Expansion Strategy with Introduction of Third Service Line

Wed, 19 Jul 2017 11:54:40 EDT

NEWPORT BEACH, CA--(Marketwired - Jul 19, 2017) - Less than a week after declaring its nationwide deployment strategy, ORHub, Inc. (OTC: ORHB) today announces its entrance into the cardiac segment of health care through the launch of its Cardiac and Cardiology service line.




AAED 2017 San Diego: Dental Marketing Firm Rosemont Media to Exhibit at Interdisciplinary Summit

Wed, 19 Jul 2017 11:01:00 EDT

San Diego-based dental website design firm Rosemont Media will be exhibiting advanced marketing technology at the American Academy of Esthetic Dentistry's 2017 Interdisciplinary Summit




Growth of Social Isolation and Loneliness in Seniors Underscores Need for Technology Solutions

Wed, 19 Jul 2017 10:30:00 EDT

Whitepaper from GreatCall and Aging in Place Technology Watch discusses health risks associated with loneliness and offers solutions to mitigate risks




The Alliance for Regenerative Medicine Announces Presenting Companies at 2017 Cell & Gene Meeting on the Mesa

Wed, 19 Jul 2017 10:16:21 EDT

WASHINGTON, DC--(Marketwired - Jul 19, 2017) - The Alliance for Regenerative Medicine (ARM) today announced the initial slate of companies selected to present at its upcoming Cell & Gene Meeting on the Mesa annual conference, October 4-6, 2017.







UPDATE - Medovex Corporation Announces First Human Cases Using Its DenerveX Device and First Revenue Events

Wed, 19 Jul 2017 09:17:59 EDT

Highly Disruptive and Patented Less Invasive Device with Faster Recovery Time than Current Surgical Treatment Options for Facet Joint Syndrome




Mobile Games Provide Inroads to Cannabis Consumers -- CFN Media

Wed, 19 Jul 2017 09:13:30 EDT

SEATTLE, WA--(Marketwired - Jul 19, 2017) -  CFN Media Group ("CannabisFN"), the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article taking a closer look at fully-reporting First Harvest Corp. (OTCQB: HVST) and how mobile games could help cannabis companies reach consumers in an otherwise off-limits advertising environment.







Invictus MD Completes First Harvest & Breaks Ground on Expansion -- CFN Media

Wed, 19 Jul 2017 09:00:00 EDT

SEATTLE, WA--(Marketwired - Jul 19, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article examining Invictus MD Strategies Corp.'s (TSX VENTURE: IMH) (OTC PINK: IVITF) progress in building out its presence in Canada's licensed producer marketplace, as well as its successful ancillary businesses.




BriaCell Provides Clinical Update on its Ongoing Phase I/IIa Clinical Study of BriaVax(TM) in Advanced Breast Cancer

Wed, 19 Jul 2017 08:30:00 EDT

BERKELEY, CA and VANCOUVER, BC--(Marketwired - July 19, 2017) - BriaCell Therapeutics Corp. ("BriaCell" or the "Company") (TSX VENTURE: BCT) (OTCQB: BCTXF), an immuno-oncology focused biotechnology company, provided a clinical update regarding its US-based open-label Phase I/IIa clinical trial evaluating the safety and efficacy of BriaVaxT, a genetically engineered whole-cell vaccine derived from a human breast cancer cell line, to treat advanced breast cancer.




CFN Media Exclusive Interview with OWCP's Dr. Sharon Rozenblat

Wed, 19 Jul 2017 08:30:00 EDT

SEATTLE, WA--(Marketwired - Jul 19, 2017) - CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article and exclusive interview with Dr. Sharon Rozenblat, Advisory Board Member for OWC Pharmaceutical Research Corp. (OTCQB: OWCP). Dr. Rozenblat is largely responsible for the development of the company's active cannabinoid topical skin cream, and the interview focuses on that product and its potential in the rapidly growing multi-billion dollar psoriasis market.




Ten Healthcare Organizations Select BIO-key Fingerprint Biometric Authentication to Meet Multifactor Authentication Requirements

Wed, 19 Jul 2017 08:03:00 EDT

Organizations find fingerprint authentication faster, more convenient and more secure than alternatives such as passwords




Washington, DC Eye Doctors to Donate Glasses to Developing Countries

Wed, 19 Jul 2017 08:01:00 EDT

The LASIK surgeons at Eye Doctors of Washington encourage their DC metro area patients to participate in a fundraiser for a non-profit providing eyewear to those who do not have access




Medovex Announces First Human Cases Using Its DenerveX Device and First Revenue Events

Wed, 19 Jul 2017 08:00:00 EDT

Highly Disruptive and Patented Less Invasive Device with Faster Recovery Time than Current Surgical Treatment Options for Facet Joint Syndrome




Medigus Expands Global Commercial Availability of MUSE Through Distribution Agreement With Izasa Hospital, S.L.U. in Spain

Wed, 19 Jul 2017 07:00:00 EDT

OMER, ISRAEL--(Marketwired - Jul 19, 2017) -  Medigus Ltd. (NASDAQ: MDGS) (TASE: MDGS), a medical device company developing minimally invasive endosurgical tools and a leader in direct visualization technology, today announced a distribution agreement in Spain with Izasa Hospital, S.L.U., a distributor of medical products in the hospital sector. The five year commercialization agreement took effect July 1, 2017; Izasa Hospital, S.L.U. will be required to purchase a minimum of EUR 1.4 million of Medigus Ultrasonic Surgical Endostapler (MUSET) equipment over the course of the agreement.




PathPartner Technology Contributes to Arthromeda's Successful Preclinical Study of Arthrosight-PS(TM) Hip Alignment Navigation System

Wed, 19 Jul 2017 03:01:00 EDT

FREMONT, CA--(Marketwired - July 19, 2017) - PathPartner Technology Inc., a technology enabler in developing intelligent systems, announces a successful cadaveric study of Arthromeda's (www.arthromeda.com) innovative patient-specific hip alignment navigation product, Arthrosight-PST.




Sacramento Plastic Surgeon Introduces Z WavePro Cellulite Therapy to Practice

Tue, 18 Jul 2017 11:01:00 EDT

Dr. Charles Perry adds innovative cellulite reduction treatment Z WavePro to his selection of non-surgical procedures as a stand-alone or multi-modality option for patients seeking smoother skin




Medifirst Solutions Signs Professional Football Player Jordan Poyer as Spokesperson for the Time Machine Laser

Tue, 18 Jul 2017 10:10:46 EDT

FREEHOLD, NJ--(Marketwired - Jul 18, 2017) - MEDIFIRST SOLUTIONS, INC. (OTC PINK: MFST) (the "Company" or "Medifirst"), a provider of innovative laser technology with its FDA 510(k) cleared Infrared Time Machine TTML-8102000 Laser Thermal Therapeutic Device, is pleased to announce that it has signed NFL player Jordan Poyer as a spokesperson for the Time Machine Laser.




Propanc Biopharma Announces Joint Research Partnership with Jaen University, Spain

Tue, 18 Jul 2017 08:30:00 EDT

MELBOURNE, AUSTRALIA--(Marketwired - July 18, 2017) - Propanc Biopharma Inc. (OTCQB: PPCB) ("Propanc Biopharma" or "the Company"), a clinical stage biopharmaceutical company focusing on development of new and proprietary treatments for cancer patients suffering from solid tumors such as pancreatic, ovarian and colorectal cancers, today announced the establishment of a 4 year joint research partnership with the Jaén University, based in Andalucía, Spain. The primary objective of the partnership is to expand Propanc Biopharma's product pipeline, by discovering new compounds based on the mode of action of naturally derived proenzymes, trypsinogen and chymotrypsinogen, which are the key active ingredients in the Company's lead product, PRP.




NetworkNewsWire Releases Exclusive Audio Interview with Algae Dynamics Corp. (ADYNF)

Tue, 18 Jul 2017 08:30:00 EDT

NEW YORK, NY--(Marketwired - Jul 18, 2017) - NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company that delivers a new generation of social communication solutions for business, today announces the online availability of its interview with Algae Dynamics Corp. (OTCQB: ADYNF).




Dewmar International BMC, Inc. (DEWM) Files Provisional Patent to Treat Lung Cancer with Cannabinoids

Tue, 18 Jul 2017 08:13:56 EDT

BATON ROUGE, LA--(Marketwired - Jul 18, 2017) -  Dewmar International BMC, Inc.  (OTC PINK: DEWM) announced today that it has filed a provisional patent with the United States Patent and Trademark Office for the treatment of lung cancer with cannabinoids. The title of the provisional patent filing is Cannabinoid Formulation to Treat Lung Cancer.




Medigus and Golden Grand Expand Distribution Arrangement in China for $27M of MUSE Systems

Tue, 18 Jul 2017 07:00:00 EDT

OMER, ISRAEL--(Marketwired - Jul 18, 2017) - Medigus Ltd. (NASDAQ: MDGS) (TASE: MDGS), a medical device company developing minimally invasive endosurgical tools and a leader in direct visualization technology, today announced that the Chinese exclusive distribution agreement with Golden Grand (Shanghai Golden Grand-Medical Instruments Ltd.) has been expanded to account for the increased interest in Medigus Ultrasonic Surgical Endostapler (MUSET) systems in China.




Cannabis Science, Inc. Finds Large-Scale Manufacturing and Product Distribution Facility in California and Eyes Nevada Property as Nevada Governor Issues Statement of Emergency Due to Potential Shortage of Cannabis

Mon, 17 Jul 2017 13:44:08 EDT

IRVINE, CA--(Marketwired - Jul 17, 2017) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, has found a California facility ideal for its large-scale manufacturing and product distribution center as it ramps up its efforts to supply cannabinoid medications in high-demand by self-medicating patients. As Nevada's Governor issues a Statement of Emergency due to the potential of limited cannabis availability, CBIS is actively looking for a similar facility in Nevada.




Advantis Corp. Ready for Ginos Roasters Product Launch

Mon, 17 Jul 2017 09:00:00 EDT

NEWPORT BEACH, CA--(Marketwired - Jul 17, 2017) - ADVANTIS CORPORATION (OTC PINK: ADVT) is prepared for the upcoming launch of Gino's Roasters pre-rolled joints later this month.




NEMUS Bioscience Announces NB2222 Pain and Anti-Addiction Data Accepted for Presentation at Upcoming Society of Neuroscience Meeting

Mon, 17 Jul 2017 08:30:00 EDT

COSTA MESA, CA--(Marketwired - Jul 17, 2017) - NEMUS Bioscience, Inc. (OTCQB: NMUS) announced that data recently obtained from the company's research and development partner, the University of Mississippi (UM), was accepted for presentation at the 2017 Annual Meeting of the Society of Neuroscience held in Washington, D.C. on November 11th-15th. The data being presented will show the superiority of the NEMUS proprietary analogue of CBD, NB2222, versus plant-derived CBD in ameliorating pain in a validated mouse (murine) model of chemotherapy-induced peripheral neuropathy using an opioid as an active comparator. Additional data will also be presented detailing the anti-addictive potential of NB2222 in an animal model of opioid addiction. The in vivo research was led by Professor Kenneth Sufka of the University of Mississippi based on the molecular cannabinoid discovery work performed by the team at ElSohly Laboratories, Inc. (ELI) in collaboration with the University, spearheaded by Dr. Mahmoud ElSohly, who also holds a faculty appointment at the University.




Medovex Corporation Announces Pricing of $2.69 Million Concurrent Registered Direct Offering and Private Placement

Mon, 17 Jul 2017 08:00:00 EDT

ATLANTA, GA--(Marketwired - Jul 17, 2017) - Medovex Corp. (NASDAQ: MDVX), a developer of medical technology products, today announced that on Friday, July 14, 2017, it entered into definitive agreements with investors for the purchase and sale of 2,956,043 shares of common stock at a price of $.91 per share in a registered direct offering and warrants to purchase up to 1,478,022 shares of common stock at an exercise price of $1.15 per share in a concurrent private placement.




Premier Biomedical, Inc. CEO Letter July 2017

Mon, 17 Jul 2017 07:00:00 EDT

EL PASO, TX--(Marketwired - Jul 17, 2017) - Greetings From The CEO and Staff at Premier Biomedical (OTCQB: BIEI)




Medifirst Solutions Answers Questions From Shareholders

Fri, 14 Jul 2017 13:10:51 EDT

FREEHOLD, NJ--(Marketwired - Jul 14, 2017) - MEDIFIRST SOLUTIONS, INC. (OTC PINK: MFST) (the "Company" or "Medifirst") would like to update shareholders in a Q&A format regarding the status of current sales and operations in connection with its FDA-cleared Infrared Time Machine TTML-8102000 Laser Thermal Therapeutic Device. The following questions were selected because they represent the most common questions asked.




Mega Bridge, Inc. Announces Name Change to HypGen, Inc. and New Strategic Direction

Fri, 14 Jul 2017 09:30:00 EDT

NEW YORK, NY--(Marketwired - Jul 14, 2017) - Mega Bridge, Inc. (OTCQB: MGBR) announced today that it is planning to change its name from Mega Bridge, Inc. to HypGen, Inc. ("HypGen") HypGen intends to focus its efforts on developing therapeutic treatment options for Parkinson's disease. To spearhead this new strategic direction, HypGen's shareholders have elected Dr. McCoy L. Moretz as the new Chief Executive Officer, Chief Financial Officer, Chief Medical Officer and Chairman of the Board of Directors. Richard Chang has also been appointed to the Board of Directors.




The Joint Commission Introduces Revised Pain Assessment and Management Standards, for Accredited Hospitals, to Include Use of Non-Pharmacologic Treatments and Strategies

Thu, 13 Jul 2017 13:55:10 EDT

The National Certification Commission for Acupuncture and Oriental Medicine (NCCAOM)(R) Stresses Importance of Including Nondrug Approaches Administered by Licensed Independent Practitioners for Pain Management